Next "Impact" Series Webinar: Developing Models that are Fit for Purpose – A Model Qualification Method

From: Toufigh Gordi Date: September 24, 2011 event Source: mail-archive.com
Developing Models that are Fit for Purpose – A Model Qualification Method by Christina Friedrich, PhD Rosa & Co. October 17, 2011 1:00 to 2:00 pm EDT You are invited to attend Dr. Friedrich's webinar Developing Models that are Fit for Purpose – A Model Qualification Method on October 17, 2011 at 1:00 pm EDT (GMT -5:00). Mechanistic physiological (“PhysioPD™”) models are graphical and mathematical representations of biology and therapeutic interventions. Strategic use of PhysioPD models and associated virtual patients and experiments can greatly enrich and reduce risk in the drug development process. Relevant models provide critical information and insights for making go/no go decisions, but positive program impact requires that decision-makers have confidence in the model. The model qualification process is specifically designed to instill confidence in mechanistic physiologic models. In this webinar, Dr. Friedrich will delineate characteristic features of mechanistic physiological models and show some examples. She will then introduce the Model Qualification Method (MQM), which defines concrete criteria for assessing model quality, building confidence, and ensuring buy-in. The MQM provides a basis for using model-based research to impact program decisions. Dr. Friedrich's presentation is a part of the monthly world-wide webinar series “Impact of Modeling & Simulation in Drug Development” hosted by Rosa & Co. LLC. The purpose of the “Impact” series is to foster the use of M&S activities in all phases of drug development by illustrating the advantages and enhancing the applicability of M&S in product discovery, development, and marketing programs. The series is intended for drug development project team members from discovery to phase 4 clinical trials. This includes pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinical development team members, regulatory affairs specialists, and other interested professionals. Register for this free webinar at www.rosaandco.com/webinar. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at http://www.rosaandco.com/webinar. Please allow 5-10 minutes for a Java applet to be installed on your computer prior to joining our webinar series for the first time. Toufigh Gordi Toufigh Gordi, PhD President, PK/PD and Clinical Pharmacology Services Rosa & Co. LLC: www.rosaandco.com E-mail: [email protected] Tel.: 408-480-7314 Fax: 408-370-9810 The information contained in this e-mail message, e-mail message sequence, and/or any enclosures is confidential, and it may be privileged and protected from unauthorized use and/or disclosure. If you are not the intended recipient, any use, dissemination, distribution, or copying is strictly prohibited. If you received this e-mail in error, PLEASE NOTIFY THE SENDER immediately and destroy this message, any enclosures, and any copies of the message and/or the enclosures. Thank you.